Miravirsen, a Novel Anti-HCV Therapeutic Targeting the Host Cell Factor miR-122, Demonstrates Broad Antiviral Activity Against Drug-Resistant HCV Variants
HEPATOLOGY(2012)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined